SOURCE: The Wiley Protocol

The Wiley Protocol

April 07, 2010 08:00 ET

T.S. Wiley, Author and Founder of the Wiley Protocol, to Speak at AMWC Conference in Monte-Carlo, Monaco

SANTA BARBARA, CA--(Marketwire - April 7, 2010) -  Wiley Systems™, Inc., developer of the Wiley Protocol biomimetic rhythmic hormones, announced today that the company's founder, T.S. Wiley, will be speaking in the Van Dongen Room, Level - 2, on Saturday, April 10 (2 - 4 p.m.) at the 8th Anti-Aging Medicine World Congress (AMWC 2010) in Monte-Carlo, Monaco. The conference, from April 8 through 10, 2010, is to be held under the High Patronage of S.A.S. Le Prince Albert II de Monaco. Wiley's lecture topic is, "Predictive Modeling of Steroid Receptors."

The AMWC 2010 Scientific Committee has invited the most distinguished international experts in anti-aging medicine, dermatology, and aesthetic surgery to share their knowledge and expertise during three days at the global multi-disciplinary congress of anti-aging medicine. Wiley Systems will also be exhibiting at Booth D2 throughout the conference.

A medical theorist in environmental endocrinology and Darwinian medicine, Wiley is a noted writer, researcher and lecturer on the effects of hormones, particularly in menopausal women as well as an accepted expert in chronobiology and circadian rhythmicity. Wiley's environmental endocrinology seminars, "Two Days Back on Earth" in Glendale, California, are attended by physicians from around the world.

T.S. Wiley, the developer of The Wiley Protocol® rhythmic, bioidentical hormones, has pioneered the standardization of the patent pending Wiley Protocol formulations using unique, standardized compounding procedures and color coded packaging, available to physicians and patients at recommended retail prices. The company's biomimetic hormone protocols must be formulated by a trained and registered compounding pharmacist.

Wiley Systems, Inc. distributes the following biomimetic dosing schedules: The Wiley Protocol™ for Women, biomimetic estradiol and progesterone restoration; Wiley Protocol for Men™, biomimetic DHEA and testosterone restoration; Wiley Protocol Thyroid™ for Women, biomimetic thyroid hormone restoration; Wiley Protocol Testosterone™ for Women, biomimetic testosterone restoration; Wiley Protocol Snooz™, recreating the night rhythms of Melatonin; Wiley Protocol Sparc™ Therapy, reestablishing the day light pulsitility of Cortisol; and Wiley Protocol Face Crème™, promoting a more youthful appearance by filling in fine lines with the body's own adiposities.

To learn more online, visit www.thewileyprotocol.com or go to the Bioidenticals Channel on YouTube where you may watch and listen to patients and doctors talk about their experiences with the rhythmic Wiley Protocol. 

About Wiley Systems, Inc. and the Wiley Protocol (www.thewileyprotocol.com)

The Wiley Systems began as a project to unite doctors and pharmacists in a common goal to standardize bioidentical hormones for academic research. The Wiley Pharmacy Consortium numbers 50 pharmacies and more than 250 doctors prescribing in the US, Canada and Australia.

The Wiley Protocol is only available at compounding pharmacies that have joined the project for future National Institutes of Health (NIH) study and have contractually agreed to the standardized methods, materials, packaging and recommended pricing. In exchange, Wiley Systems provides intellectual property and provides 28WP logo-bearing packaging consisting of color-coded bags and applicators. The Wiley Protocol name assures customers that they are receiving authentic Wiley Protocol dosing rhythms based on original research.

Contact Information